Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
16 results
D2.133 - Clinical and Direct Medical Burden of Hospitalized Children with Asthma Exacerbations
D2.135 - What are our children breathing? Tracking exposure to air pollution during a school day
D2.136 - Nasal transcriptomics as a biomarker for ICS/LABA treatment in paediatric asthma in the PUFFIN study
D2.137 - Long term, Persistent Eosinophilia in patients with Asthma and CRSwNP undergoing Dupilumab therapy: preliminar results of a 24-month follow up prospective study
D2.138 - The Effect of Human Milk Oligosaccharides 2’FL and 3FL on Macrophage polarization
D2.139 - Oxidative stress and tissue hypoxia are triggered through the increased respiratory effort during sleep and reflect the inflammation as a stress link in the gut-brain axis in children suffering asthma, allergic/non-allergic rhinitis, and/or eczema
D2.140 - Allergic Sensitization Patterns in Western Romania: Impact of Airborne Allergens and Climate Factors
D2.142 - Smoking cessation advice to parents in children with bronchial asthma- still it is a long way to go
D2.144 - Occupational Asthma due to garlic powder: a case report
D2.145 - The utility of blood eosinophils, IgE and skin prick testing in paediatric asthma diagnosis
D2.146 - Occupational Asthma due to Subtilisin: the power of specific inhalation challenge
D2.147 - Comparison of clinical outcomes with Benralizumab in severe eosinophilic asthma: Switched and naïve patients
D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma
D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix
Download the app
The congress at your fingertips
Available on
Download